Page
%P
-
Article
Open AccessHetero-modification of TRAIL trimer for improved drug delivery and in vivo antitumor activities
Poor pharmacokinetics and resistance within some tumor cell lines have been the major obstacles during the preclinical or clinical application of TRAIL (tumor-necrosis-factor (TNF)-related apoptosis-inducing l...